Why is Sun Pharma betting $11.75B on a struggling US drugmaker?
In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash deal valued at $11.8 billion The logic of the deal is easy to state and harder to execute as Sun is not buying a fast-growing asset, but a scaled global platform with meaningful cash flow, a large commercial footprint and a huge debt load. Sun is planning to expand in women's health, biosimilars and innovative medicines, while Organon brings more than 70 products across women's health and general medicines in 140 countries.
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share.
Sun Pharmaceutical to Acquire Organon Valued at $11.75 Billion
Sun Pharma has offered to pay $14.00 a share in an all-cash deal.
Sun Pharma to acquire Organon in $11.75 bln all-cash deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion, the companies said in a joint statement on Sunday.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Rises Higher Than Market: Key Facts
The latest trading day saw Organon (OGN) settling at $9.33, representing a +1.3% change from its previous close.
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Organon (OGN) closed at $8.54, marking a -3.28% move from the previous day.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
This Women's Healthcare Stock Is Up 15% on Reports of a Takeover In the Works
Organon shares are popping Friday on signs of a takeover deal.
Organon (OGN) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Organon (OGN) closed at $6.05, indicating a -4.87% shift from the previous trading day.
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Organon (OGN) closed at $5.84, marking a -3.47% move from the previous day.
